FDA Inspection
Row1 Inc. dba Regenative LabsRow1 Inc. dba Regenative Labs – FDA Inspection, Mar 30, 2022
Record Details
This FDA Inspection record concerns Row1 Inc. dba Regenative Labs, with an inspection on March 30, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 30, 2022
- Product Type
- Biologics
View Company Profile
ID · e4b46d9e-2a41-4147-9e55-8aae3004143a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1165813
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Enforcement
- Warning Letter
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.